Radiant Innovation

Radiant Innovation Current Liabilities

Current Liabilities of Radiant Innovation (3373.TWO) as of Nov 20, 2026.

Current Liabilities

-TWD

Last updated:

Current Liabilities of Radiant Innovation is 2026 - TWD. Current Liabilities of Radiant Innovation was 2025 - TWD. It decreases by % lower compared to the previous year.

The Radiant Innovation Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2011
115.78 M TWD
Jan 1, 2012
97.97 M TWD
Jan 1, 2013
115.67 M TWD
Jan 1, 2014
154.04 M TWD
Jan 1, 2015
147.12 M TWD
Jan 1, 2016
119.67 M TWD
Jan 1, 2017
104.13 M TWD
Jan 1, 2018
119.02 M TWD
The Radiant Innovation Current Liabilities history
YEARCurrent LiabilitiesYoY
119.02 MTWD+14.30%
104.13 MTWD-12.99%
119.67 MTWD-18.66%
147.12 MTWD-4.49%
154.04 MTWD+33.17%
115.67 MTWD+18.07%
97.97 MTWD-15.38%
115.78 MTWD-3.20%
119.60 MTWD-25.11%
159.71 MTWD+35.11%
118.20 MTWD+35.77%
87.06 MTWD-8.80%
95.46 MTWD+29.53%
73.70 MTWD+163.23%
28.00 MTWD+5.78%
26.47 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

On Eulerpool you can find the complete historical development of Current Liabilities Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Radiant Innovation

All Key Metrics — Radiant Innovation